StockData
Burning Rock Biotech Ltd logo

Burning Rock Biotech Ltd (BNR) stock

BNRNasdaqServices-Medical Laboratories
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$12.50−0.24 (-1.88%)

Close on Nov 17, 2026Market cap $136.07MP/E –Yield –

Burning Rock Biotech total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Burning Rock Biotech's total debt was CN¥1.70M at Dec 31, 2025. For fiscal 2025 it was CN¥1.70M. The highest annual figure on record is CN¥20.64M in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025CN¥1.70M–
FY2024Dec 31, 2024CN¥0–
FY2022Dec 31, 2022CN¥0–
FY2021Dec 31, 2021CN¥0-100.0%
FY2020Dec 31, 2020CN¥3.28M-84.1%
FY2019Dec 31, 2019CN¥20.64M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025CN¥1.70M–
Q4 FY2024Dec 31, 2024CN¥0-100.0%
Q4 FY2022Dec 31, 2022CN¥0-100.0%
Q2 FY2022Jun 30, 2022CN¥2.37M–
Q4 FY2021Dec 31, 2021CN¥0–
Q4 FY2020Dec 31, 2020CN¥3.28M–
Q4 FY2019Dec 31, 2019CN¥20.64M–

More Burning Rock Biotech figures

See a number that looks wrong?